Publications by authors named "David V Gold"

Claim this Profile
I
Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: a promising biomarker and therapeutic target for pancreatic cancer.
Donglin Liu, Chien-Hsing Chang, David V Gold, David M Goldenberg

Oncotarget· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic and therapeutic implications of a novel immunohistochemical panel detecting duodenal mucosal invasion by pancreatic ductal adenocarcinoma.
Sabrina C Sopha, Purva Gopal, Nipun B Merchant, Frank L Revetta, David V Gold

Int J Clin Exp Pathol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation of pancreatic ductal adenocarcinoma from chronic pancreatitis by PAM4 immunohistochemistry.
Chanjuan Shi, Nipun Merchant, Guy Newsome, David M Goldenberg, David V Gold

Arch Pathol Lab Med· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology.
David M Goldenberg, David V Gold, Meiyu Loo, Donglin Liu, Chien-Hsing Chang

PLoS One· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin.
David V Gold, Guy Newsome, Donglin Liu, David M Goldenberg

Mol Cancer· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Milatuzumab-SN-38 conjugates for the treatment of CD74+ cancers.
Serengulam V Govindan, Thomas M Cardillo, Robert M Sharkey, Fatma Tat, David V Gold, David M Goldenberg

Mol Cancer Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAM4 enzyme immunoassay alone and in combination with CA 19-9 for the detection of pancreatic adenocarcinoma.
David V Gold, Jochen Gaedcke, B Michael Ghadimi, Michael Goggins, Ralph H Hruban, David M Goldenberg

Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of acute graft-versus-host disease in a xenogeneic SCID mouse model by the humanized anti-CD74 antagonistic antibody milatuzumab.
Xiaochuan Chen, Chien-Hsing Chang, Rhona Stein, Thomas M Cardillo, David V Gold, David M Goldenberg

Biol Blood Marrow Transplant· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fractionated radioimmunotherapy with (90) Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer: A phase 1 trial.
Allyson J Ocean, Kenneth L Pennington, Michael J Guarino, Arif Sheikh, Tanios Bekaii-Saab, Stanley J Goldsmith, David V Gold, David M Goldenberg

Cancer· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo.
David M Goldenberg, David Zagzag, Kerstin M Heselmeyer-Haddad, Lissa Y Berroa Garcia, Thomas Ried, David V Gold

Int J Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a non-viral vaccine in smallpox-vaccinated individuals and immunized HLA-transgenic mice.
Alice P Taylor, Boby Makabi-Panzu, Xiaochuan Chen, David V Gold, David M Goldenberg

Hum Immunol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of advanced pancreatic carcinoma with 90Y-Clivatuzumab Tetraxetan: a phase I single-dose escalation trial.
Seza A Gulec, Steven J Cohen, Kenneth L Pennington, Lionel S Zuckier, Ralph J Hauke, David V Gold, David M Goldenberg

Clin Cancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of early-stage pancreatic adenocarcinoma.
David V Gold, Michael Goggins, David E Modrak, Guy Newsome, Mengling Liu, David M Goldenberg

Cancer Epidemiol Biomarkers Prev· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced expression of CD74 in gastrointestinal cancers and benign tissues.
David V Gold, Rhona Stein, Jack Burton, David M Goldenberg

Int J Clin Exp Pathol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretargeted radioimmunotherapy of pancreatic cancer xenografts: TF10-90Y-IMP-288 alone and combined with gemcitabine.
Habibe Karacay, Robert M Sharkey, David V Gold, Dan R Ragland, William J McBride, David M Goldenberg

J Nucl Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines.
David E Modrak, Evelyn Leon, David M Goldenberg, David V Gold

Mol Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
David V Gold, David M Goldenberg, Habibe Karacay, Edmund A Rossi, Chien-Hsing Chang

Cancer Res· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma.
David V Gold, Zarir Karanjawala, David E Modrak, David M Goldenberg, Ralph H Hruban

Clin Cancer Res· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sphingolipid targets in cancer therapy.
David E Modrak, David V Gold, David M Goldenberg

Mol Cancer Ther· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New MUC1 serum immunoassay differentiates pancreatic cancer from pancreatitis.
David V Gold, David E Modrak, Zhiliang Ying, Thomas M Cardillo, Robert M Sharkey, David M Goldenberg

J Clin Oncol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a Mu-9 (anti-colon-specific antigen-p)-reactive peptide having homology to CA125 (MUC16).
David E Modrak, Habibe Karacay, Thomas M Cardillo, Guy Newsome, David M Goldenberg, David V Gold

Int J Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer.
David E Modrak, Thomas M Cardillo, Guy A Newsome, David M Goldenberg, David V Gold

Cancer Res· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD74 is expressed by multiple myeloma and is a promising target for therapy.
Jack D Burton, Scott Ely, Praveen K Reddy, Rhona Stein, David V Gold, David M Goldenberg

Clin Cancer Res· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Thomas M Cardillo, Habibe Karacay, David M Goldenberg, Dion Yeldell, Chien-Hsing Chang, David V Gold

Clin Cancer Res· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined 90Yttrium-DOTA-labeled PAM4 antibody radioimmunotherapy and gemcitabine radiosensitization for the treatment of a human pancreatic cancer xenograft.
David V Gold, David E Modrak, Keith Schutsky, Thomas M Cardillo

Int J Cancer· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis